AiCure

Articles Published in 2007

Premier’s Management Makes Preliminary Bid for Company

Wednesday, August 29, 2007 02:22 PM

Some of Premier Research Group’s top management made a preliminary approach to its board, exploring an offer to buy the contract research organization (CRO), according to Thomson Financial.

More... »


Cymbalta Reduces Pain in Fibromyalgia Trial

Tuesday, August 28, 2007 03:56 PM

Eli Lilly reported positive results from a phase III trial of Cymbalta (duloxetine) for the treatment of fibromyalgia. Cymbalta is Lilly’s serotonin and norepinephrine reuptake inhibitor (SSNRI), approved in the U.S. for major depression and diabetic (peripheral neuropathic) pain. Merrill Lynch has forecasted the product could reach worldwide sales of $2.2 billion in 2008.

More... »


Averion Reports Second Quarter Loss

Monday, August 27, 2007 05:31 PM

The Boston-based contract research organization (CRO) Averion International reported a net operating loss of $577,253 for the second quarter of 2007 on total revenues of $9.81 million. That compared to a loss of $912,140 during the same period last year from just $4.92 million in revenue. For the first half of the year – ending June 30th of 2007 – Averion reported $19.1 million in revenue and a net loss of $2.47 million compared with $9.88 million in revenue and a net loss of $1.94 million during the same period in 2006.

More... »

Top Stories for the Week of August 20th 2007

Friday, August 24, 2007 07:45 AM

Top News

More... »

Lupus Drug Shows Promise in Phase I/II Trial

Wednesday, August 22, 2007 07:26 AM

UCB and Immunomedics reported positive results from a follow-up phase I/II trial of epratuzumab for the treatment of systemic lupus erythematosus (SLE). Phase I of the trial enrolled 12 subjects with SLE and analyzed the effect of epratuzumab on circulatory B-cell subsets. Results showed that epratuzumab preferentially targets naive and transitional B-cells.

More... »

Datatrak Revenue Down 37% in Q2

Tuesday, August 21, 2007 07:29 AM

Datatrak, an electronic data capture company, reported its second quarter revenue slumped 37% to $3.07 million and a net loss of $2.97 million or $0.22 per share on a basic and diluted basis. These results compared with revenue of $4.83 million and a net loss of $702,000, or $0.06 per share basic and diluted basis, in the second quarter of 2006. Datatrak laid off 17 employees in the second quarter, recording severance charges totaling $337,000.

More... »

CenterWatch Monthly: August 2007 Issue

Monday, August 20, 2007 03:45 PM

Venture Philanthropy on the Rise

More... »

Top Stories for the Week of August 13th 2007

Friday, August 17, 2007 12:10 PM

Top News

More... »

Recent Industry Personnel News

Wednesday, August 15, 2007 04:22 PM
  • Wilmington, N.C.-based contract research organization (CRO) PPD promoted Susan Atkinson to senior vice president for global statistics and data management. Her duties will include overseeing electronic data capture operations and informatics. Atkinson began at PPD in 1991 as a senior biostatistician and most recently led PPD’s U.S. biostatistics, programming and data management operations.

More... »

Venture Philanthropy is on the Rise, Reaches $75M in 2007

Monday, August 13, 2007 07:57 AM

Venture philanthropy is a term coined in the past few years to describe the funding that disease foundations provide to biopharmaceutical companies to research potential drugs and therapies in their respective diseases. Investment by U.S. disease foundations in the biopharmaceutical industry this year will be about $75 million—10 times as much as its investment in 2000, according to CenterWatch estimates.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs